Delivery Order SPE2DU25D4211-SPE2DU26FB955
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,393.67 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This is a firm fixed price delivery order with an ultimate completion date of October 21, 2025, issued under a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,599.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, with completion scheduled for December 5, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made on a competitive, non-set-aside basis to the major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $93,513.00 to AmerisourceBergen Drug Corp on October 21, 2025, for pharmaceutical products and medical supplies. This firm fixed-price delivery order, which is non-competitive and carries an ultimate completion date of October 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,085.04 to AmerisourceBergen Drug Corp on December 17, 2025, for pharmaceutical products and medical supplies. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a $13,421.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, with an ultimate completion date of the same day. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,765.33 to AmerisourceBergen Drug Corp for pharmaceutical products and services, with an ultimate completion date of January 2, 2026. This firm fixed-price delivery order, issued on December 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. No...
- The Defense Logistics Agency awarded a delivery order valued at $1,540.52 to AmerisourceBergen Drug Corp on December 1, 2025, with an ultimate completion date of December 22, 2025. This firm fixed price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,073.06 by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order was placed under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency has awarded a delivery order valued at $1,193.14 to AmerisourceBergen Drug Corp for pharmaceutical products and services under a Firm Fixed Price contract. This non-set-aside delivery order, issued on January 2, 2026, will be completed by January 5, 2026, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $9,211.35 to AmerisourceBergen Drug Corp for pharmaceutical products and supplies under a firm fixed price contract. This competitively awarded, non-set-aside delivery order was issued on November 5, 2025, with an ultimate completion date of the same date. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a child contract action under the...
- SPE2DU25D4211Indefinite Delivery Contract
- SPE2DU25D4211-SPE2DU26FB955Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,460.13 to AmerisourceBergen Drug Corp for pharmaceutical products and services. This firm fixed-price delivery order, issued on January 2, 2026, with an ultimate completion date of the same day, represents a child order under a larger contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the vendor's demonstrated capability to meet federal procurement requirements through open competition. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen serves as a prime contractor supplying a broad range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates its role as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts that may involve multiple regional awards among different contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 1/1/26 |